Preclinical
Are you fascinated with microbiology? Have you ever thought about how to integrate your passion for research and entrepreneurship? The field of microbiology is expanding and being significantly impacted by advancements in technology.
The Christiana Care Health System’s Gene Editing Institute, based in Wilmington, Del., is pulling together a preliminary investigational new drug application (IND) for the U.S. Food and Drug Administration (FDA).
Recently, researchers with the Institute of Life in Athens, Greece, announced that a healthy baby boy was born who basically had the DNA from three people. The child was born to a 32-year-old woman who had failed in four cycles of in vitro fertilization (IVF).
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Researchers with the University of California San Francisco (UCSF) developed a “neural decoder” that translates brain activity to synthesize audible speech. They published their research in the journal Nature.
Researchers at Sweden’s Lund University reported that a blood test can reveal whether there is accelerating nerve cell damage in the brain.
The two companies will combine their expertise to drive new immunology candidates toward the clinic.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Researchers at Yale University were able to restore basic cellular activity in the brains of pigs only hours after their deaths. They published their work in the journal Nature.
The vast majority of immune cells are found in the gut but historically, the gut has been viewed as a liability to drug development. The question of whether or not greater understanding of harnessing the gut could drive more promising drug development has led to the formation of a new company, Kintai Therapeutics.
PRESS RELEASES